Class 3 Medicines Recall: Theramex Ireland Ltd T/A Theramex HQ UK Ltd, AlfaD Capsules, EL (20) A/46

Theramex Ireland Ltd T/A Theramex HQ UK Ltd has informed us that when decommissioning at the pharmacy and when scanning the serialised 2D code, the status of certain packs of AlfaD capsules may report as ‘EXPORT’

Product information

PL Number(s)

  • AlfaD 0.25 microgram Capsules, PL 49876/0001
  • AlfaD 1 microgram Capsules, PL 49876/0003

MDR Number

MDR 144-09/20

Company name

Theramex Ireland Ltd T/A Theramex HQ UK Ltd

Product description

AlfaD 0.25 microgram Capsules:

  • Batch Number: A04285
  • Expiry Date: Apr 2022
  • Pack Size: 30
  • First Distributed: 15 Sep 2020

AlfaD 1 microgram Capsules:

  • Batch Number: 106389
  • Expiry Date: Aug 2022
  • Pack Size: 30
  • First Distributed: 15 Sep 2020

Active Pharmaceutical Ingredient: alfacalcidol

Brief description of the problem

Theramex Ireland Ltd T/A Theramex HQ UK Ltd has informed us of an issue related to error in the decommissioning of the above batches. Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘EXPORT’. Although there is no risk to product quality, any remaining stock should be quarantined and returned.

Advice for healthcare professionals

Stop supplying the above batch. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Further Information

For stock control enquiries please contact Theramex HQ UK Ltd Customer Services Team on 020 3962 5532.

For medical information enquiries please contact Theramex HQ UK Ltd Medical Information Department on 033 3009 6795.

Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this notice.

NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

Download the document

EL (20)A 46

Published 29 September 2020